The United Kingdom is witnessing a remarkable shift in its understanding towards psychedelics. What began with a emerging exploration of psilocybin and traditional Ayahuasca is now developing to include more experimental substances like copyright and potentially research into clinical uses. This burgeoning interest is fuelled by both promising find